With the rising temperatures in spring and summer, ticks also become more active again. They are practically everywhere where there are plants. They are waiting in exposed places such as grass for a desirable host to pass by and latch onto it when they make contact. In humans, they usually crawl into protected body regions […]
Press release CE-marked antibody tests expand EUROIMMUN’s comprehensive portfolio of laboratory products to support the analysis of the immune response to COVID-19 EUROIMMUN today announced the launch of two CE marked assays – the Anti-SARS-CoV-2 RBD ChLIA (IgG) and the Anti-SARS-CoV-2 Omicron ELISA (IgG). Both test systems enable the detection of IgG antibodies formed against
Reliable and fast diagnostics of cervical cancer While HPV tests detect infections with HPV and thus allow drawing conclusions on the risk of developing cervical cancer, the GynTect® test can be used in a second step to clarify whether affected cells are actually already developing into cancer cells based on the detection of epigenetic markers.
With its newly developed software platform “EUROLabPolaris” EUROIMMUN meets the demands in the increasingly globalised field of laboratory diagnostics by enabling large laboratory groups to work together on digitally-supported immunofluorescence diagnostics across several sites. In an interview Timo Schütze, the product manager responsible for the software, and Moritz Pavlik, the product manager responsible for IT
Emerging infectious diseases is a term for new infectious diseases in humans that have either newly appeared in a population or have already existed but are rapidly increasing in incidence or geographic range. The term also covers diseases that are caused by novel pathogens. These have developed from bacteria or viruses that were previously harmless
